Dette kan medføre efterfølgende komplikationer, f. eks. cellulitis, erysipelas eller, potentielt med dødeligt udfald, staphylococcal scalded skin syndrome (SSSS) eller sepsis.
21 Skin lesions induced by cetuximab may predispose patients to superinfections (e. g. with S. aureus), which may lead to subsequent complications, e. g. cellulitis, erysipelas, or, potentially with fatal outcome, staphylococcal scalded skin syndrome or sepsis.